drugset / Trial / NCT05108545
A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, single-arm, phase III study to evaluate the safety and efficacy of Amphotericin B liposomes in patients with persistent neutropenia and fever.
Timeline
- Start
- 2021-12-15
- Primary completion
- 2022-07-31
- Completion
- 2023-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amphotericin B | Unknown | 3 mg/kg | Intravenous |